Discrimination of breast cancer from healthy breast tissues using a three-component diffusion-weighted MRI model
Maren M Sjaastad Andreassen,
Ana E Rodriguez-Soto,
Christopher C. Conlin,
Tyler M Seibert,
Anne M. Wallace,
Grace S Ahn,
Neil P. Jerome,
Tone F Bathen,
Paal Erik Goa,
Anders M. Dale
Posted 04 Sep 2020
medRxiv DOI: 10.1101/2020.09.03.20179481
Posted 04 Sep 2020
Purpose: Diffusion-weighted magnetic resonance imaging (DW-MRI) is a contrast-free modality that has demonstrated ability to discriminate between pre-defined benign and malignant breast lesions. However, the ability of DW-MRI to discriminate cancer tissue from all other breast tissues in a clinical setting is unknown. Here we explore the ability to distinguish breast cancer from healthy breast tissues using signal contributions from the newly developed three-component multi-b-value DW-MRI model. Experimental design: Pathology-proven breast cancer patients from two datasets (n=81 and n=25) underwent multi-b-value DW-MRI. The three-component signal contributions C1 and C2 and their product, C1C2, were compared to the image defined on maximum b-value (DWImax), conventional apparent diffusion coefficient (ADC), and apparent diffusion kurtosis (Kapp). Ability to discriminate between cancer and healthy breast tissues was assessed by the false positive rate given sensitivity of 80% (FPR80) and receiver operating characteristic (ROC) area under the curve (AUC). Results: Mean FPR80 for both datasets was 0.016 (95%CI=0.008-0.024) for C1C2, 0.136 (95%CI=0.092-0.180) for C1, 0.068 (95%CI=0.049-0.087) for C2, 0.159 (95%CI=0.114-0.204) for DWImax, 0.731 (95%CI=0.692-0.770) for ADC and 0.684 (95%CI=0.660-0.709) for Kapp. Mean ROC AUC for C1C2 was 0.984 (95%CI=0.977-0.991). Conclusions: The three-component model yields a clinically useful discrimination between cancer and healthy breast tissues, superior to other DW-MRI methods and obliviating pre-defining lesions by radiologists. This novel DW-MRI method may serve as non-contrast alternative to standard-of-care dynamic contrast-enhanced MRI (DCE-MRI); removing the need to administer Gadolinium contrast decreases scan time and any accumulation of Gadolinium in the brain.
- Downloaded 345 times
- Download rankings, all-time:
- Site-wide: 96,440
- In radiology and imaging: 173
- Year to date:
- Site-wide: 52,461
- Since beginning of last month:
- Site-wide: 42,889
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!